4.8 Review

The twin cytokines interleukin-34 and CSF-1: masterful conductors of macrophage homeostasis

期刊

THERANOSTICS
卷 11, 期 4, 页码 1568-1593

出版社

IVYSPRING INT PUBL
DOI: 10.7150/thno.50683

关键词

IL-34; inflammation; macrophage differentiation; theranostics; tumor

向作者/读者索取更多资源

Macrophages are specialized cells that control tissue homeostasis, relying on specific growth factors and receptors for differentiation and polarization. Macrophage-colony stimulating factor (CSF-1) and interleukin-34 (IL-34) are twin cytokines that share a common receptor, activating similar signaling pathways with some differential activation leading to specific activities.
Macrophages are specialized cells that control tissue homeostasis. They include non-resident and tissue-resident macrophage populations which are characterized by the expression of particular cell surface markers and the secretion of molecules with a wide range of biological functions. The differentiation and polarization of macrophages relies on specific growth factors and their receptors. Macrophage-colony stimulating factor (CSF-1) and interleukine-34 (IL-34), also known as twin cytokines, are part of this regluatory landscape. CSF-1 and IL-34 share a common receptor, the macrophage-colony stimulating factor receptor (CSF-1R), which is activated in a similar way by both factors and turns on identical signaling pathways. However, there is some discrete differential activation leading to specific activities. In this review, we disscuss recent progress in understanding of the role of the twin cytokines in macrophage differentiation, from their interaction with CSF-1R and the activation of signaling pathways, to their implication in macrophage polarization of non-resident and tissue-resident macrophages. A special focus on IL-34, its involvement in pathophsyiological contexts, and its potential as a theranostic target for macrophage therapy will be proposed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据